Trends in Immunotherapy

Article

Association between Systemic Immune‑Inflammation Index and Mortality in Type 2 Diabetes Patients Complicated with Ischemic Stroke: A Retrospective Cohort Study

Downloads

https://doi.org/10.54963/ti.v9i1.966
Zhu, H., & Shao, G. (2025). Association between Systemic Immune‑Inflammation Index and Mortality in Type 2 Diabetes Patients Complicated with Ischemic Stroke: A Retrospective Cohort Study. Trends in Immunotherapy, 9(1), 79–90. https://doi.org/10.54963/ti.v9i1.966
Volume 9 Issue 1 (2025)
Copyright (c) 2025 Hongwei Zhu, Guo Shao
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

License

Trends in Immunotherapy (TI)  publishes accepted manuscripts under Creative Commons Attribution 4.0 International (CC BY 4.0). Authors who submit their papers for publication by TI agree to have the CC BY 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for any purpose, including commercial use. As long as the author and original source are properly cited, anyone may copy, redistribute, reuse, and transform the content.

Authors

Background: When type 2 diabetes mellitus (T2DM) occurs concomitantly with ischemic stroke, it poses a major challenge to global public health and is related to poor prognosis. Inflammation is a crucial factor driving the progression of this condition. The systemic immune-inflammation index (SII), which was considered capable of comprehensively assessing the overall immunity and inflammation, has a relationship with the mortality of T2DM patients suffering from ischemic stroke that has not yet been fully clarified. This study seeks to investigate the relationship between SII and mortality at 28 days and one year in T2DM patients complicated with ischemic stroke. Methods: The research utilized data from the MIMIC-IV database, with participants categorized into three groups based on SII tertiles. The primary outcome focused on mortality at 28 days and one year. The association between SII and mortality was assessed through smoothed curve fitting methods and multivariate Cox regression analyses. To analyse cumulative survival rates across these time frames, Kaplan-Meier curves were employed. Additionally, receiver-operating characteristic (ROC) curves were generated to gauge the predictive capabilities of SII. To ensure the reliability of the findings, subgroup analyses were performed. Results: This study evaluated a total of 1,204 patients. The results indicated that an increase in SII correlated with an increased likelihood of mortality at both 28 days and one year among individuals with T2DM complicated by ischemic stroke. Higher levels of SII were significantly linked to an elevated hazard ratio for 28-day (HR: 1.43, P<0.01) and 1-year (HR: 1.27, P<0.01) mortality in this patient group. A nonlinear relationship between SII and mortality in this patient population was evident from the smoothed fitting curve (P<0.01). The ROC analysis demonstrated that SII outperformed both the SOFA and GCS scores in predicting mortality in this patient population. The decision curve analysis reinforced that SII offered a superior net benefit compared to the SOFA and GCS scores. Subgroup analyses showed no significant interaction between SII and all subgroups (P value of interaction >0.05). Conclusion: In T2DM patients with ischemic stroke, higher SII levels correlated with increased mortality at 28 days and one year. 

Keywords:

Type 2 Diabetes Mellitus (T2DM); Ischemic Stroke; Systemic Immune‑Inflammation Index (SII); Mor‑ tality

References

  1. Luger, S.; Schwebler, A.; Vutukuri, R. Beta adrenoceptor blockade ameliorates impaired glucose tolerance and alterations of the cerebral ceramide metabolism in an experimental model of ischemic stroke. Ther. Adv. Neurol. Disord. 2018, 11, 1756286418769830. DOI: http://doi.org/10.1177/1756286418769830
  2. Wang, X.; Li, R.; Zacharek, A.; et al. ApoA‑I mimetic peptide reduces vascular and white matter damage after stroke in type‑2 diabetic mice. Front. Neurosci. 2019, 13, 1127. DOI: http://doi.org/10.3389/fnins.2019.01127
  3. Yan, T.; Venkat, P.; Chopp, M.; et al. Neurorestorative responses to delayed human mesenchymal stromal cells treatment of stroke in type 2 diabetic rats. Stroke 2016, 47, 2850–2858. DOI: http://doi.org/10.1161/strokeaha.116.014686
  4. Venkat, P.; Chopp, M.; Chen, J. Cell‑based and exosome therapy in diabetic stroke. Stem Cells Transl. Med. 2018, 7, 451–455. DOI: http://doi.org/10.1002/sctm.18-0014
  5. Kuts, R.; Frank, D.; Gruenbaum, B.F.; et al. A novel method for assessing cerebral edema, infarcted zone and blood‑brain barrier breakdown in a single post‑stroke rodent brain. Front. Neurosci. 2019, 13, 1105. DOI: http://doi.org/10.3389/fnins.2019.01105
  6. Li, Z.H.; Zhong, W.F.; Lv, Y.B.; et al. Associations of plasma high‑sensitivity C‑reactive protein concentrations with all‑cause and cause‑specific mortality among middle‑aged and elderly individuals. Immunity Ageing 2019, 16, 1–8. DOI: http://doi.org/10.1186/s12979-019-0168-5
  7. Huang, J.H.; Tsai, L.C.; Chang, Y.C.; et al. High or low calcium intake increases cardiovascular disease risks in older patients with type 2 diabetes. Cardiovasc. Diabetol. 2014, 13, 1–10. DOI: http://doi.org/10.1186/s12933-014-0120-0
  8. Neumann, S.; Boothman‑Burrell, L.; Gowing, E.K.; et al. The delta‑subunit selective GABA A receptor modulator, DS2, improves stroke recovery via an anti‑inflammatory mechanism. Front. Neurosci. 2019, 13, 1133. DOI: http://doi.org/10.3389/fnins.2019.01133
  9. Li, L.; Cheng, S.Q.; Guo, W.; et al. Oridonin prevents oxidative stress‑induced endothelial injury via promoting NRF‑2 pathway in ischaemic stroke. J. Cell Mol. Med. 2021, 25, 9753–9766. DOI: http://doi.org/10.1111/jcmm.16923
  10. Liao, M.; Li, F.; Hu, J.; Yang, J.; et al. High neutrophil counts before endovascular treatment for acute basilar artery occlusion predict worse outcomes. Front. Aging Neurosci. 2022, 14, 978740. DOI: http://doi.org/10.3389/fnagi.2022.978740
  11. Brait, V.H.; Arumugam, T.V.; Drummond, G.R.; et al. Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J. Cereb. Blood Flow Metab. 2012, 32, 598–611. DOI: http://doi.org/10.1038/jcbfm.2012.6
  12. Bai, M.; Sun, R.; Cao, B.; Feng, J.; et al. Monocyte‑related cytokines/chemokines in cerebral ischemic stroke. CNS Neurosci. Ther. 2023, 29, 3693–3712. DOI: http://doi.org/10.1111/cns.14368
  13. Zhu, F.; Ji, Y.; Song, J.H.; et al. Correlations between NLR, NHR, and clinicopathological characteristics, and prognosis of acute ischemic stroke. Medicine 2023, 102, e33957. DOI: http://doi.org/10.1097/md.0000000000033957
  14. Xu, C.; Cai, L.; Yi, T.; et al. Neutrophil‑to‑lymphocyte ratio is associated with stroke progression and functional outcome in patients with ischemic stroke. Brain Behav. 2023, 13, e3261. DOI: http://doi.org/10.1002/brb3.3261
  15. Li, W.; Hou, M.; Ding, Z.; et al. Prognostic value of neutrophil‑to‑lymphocyte ratio in stroke: a systematic review and meta‑analysis. Front. Neurol. 2021, 12, 686983. DOI: http://doi.org/10.3389/fneur.2021.686983
  16. Wang, X.; Ni, Q.; Wang, J.; et al. Systemic inflammation response index is a promising prognostic marker in elderly patients with heart failure: a retrospective cohort study. Front. Cardiovasc. Med. 2022, 9, 871031. DOI: http://doi.org/10.3389/fcvm.2022.871031
  17. Liu, B.; Wang, J.; Li, Y.Y.; et al. The association between systemic immune‑inflammation index and rheumatoid arthritis: evidence from NHANES 1999–2018. Arthritis Res. Ther. 2023, 25, 34.
  18. Luo, Z.; Wang, W.; Xiang, L.; et al. Association between the systemic immune‑inflammation index and prostate cancer. Nutr. Cancer 2023, 75, 1918–1925. DOI: http://doi.org/10.1080/01635581.2023.2272800
  19. Jiang, D.; Bian, T.; Shen, Y.; et al. Association between admission systemic immune‑inflammation index and mortality in critically ill patients with sepsis: a retrospective cohort study based on MIMIC‑IV database. Clin. Exp. Med. 2023, 23, 3641–3650.
  20. Song, Y.; Guo, W.; Li, Z.; et al. Systemic immune‑inflammation index is associated with hepatic steatosis: evidence from NHANES 2015‑2018. Front. Immunol. 2022, 13, 1058779. DOI: http://doi.org/10.3389/fimmu.2022.1058779
  21. Zheng, H.; Yin, Z.; Luo, X.; et al. Associations between systemic immunity‑inflammation index and heart failure: Evidence from the NHANES 1999–2018. Int. J. Cardiol. 2024, 395, 131400. DOI: http://doi.org/10.1016/j.ijcard.2023.131400
  22. Lv, H.; Chen, X.; Chen, X.; et al. High Expression of NLR and SII in patients with Nasopharyngeal Carcinoma as Potential Prognostic Observations. Cancer Control 2024, 31, 10732748241288106. DOI: http://doi.org/10.1177/10732748241288106
  23. Yan, D.; Dai, C.; Xu, R.; et al. Predictive ability of systemic inflammation response index for the risk of pneumonia in patients with acute ischemic stroke. Gerontology 2023, 69, 181–188. DOI: http://doi.org/10.1159/000524759
  24. Cheng, W.; Bu, X.; Xu, C.; et al. Higher systemic immune‑inflammation index and systemic inflammation response index levels are associated with stroke prevalence in the asthmatic population: a cross‑sectional analysis of the NHANES 1999‑2018. Front. Immunol. 2023, 14, 1191130. DOI: http://doi.org/10.3389/fimmu.2023.1191130
  25. Wang, H.; Nie, H.; Bu, G.; et al. Systemic immune‑inflammation index (SII) and the risk of all‑cause, cardiovascular, and cardio‑cerebrovascular mortality in the general population. Eur. J. Med. Res. 2023, 28, 575. DOI: http://doi.org/10.1186/s40001-023-01529-1
  26. Liang, L.; Su, Q. Systemic immune‑inflammation index and the short‑term mortality of patients with sepsis: A meta‑analysis. Biomolecules Biomed. 2025, 1–12. DOI: http://doi.org/10.17305/bb.2024.11494
  27. Cao, Y.; Li, P.; Zhang, Y.; et al. Association of systemic immune inflammatory index with all‑cause and cause‑specific mortality in hypertensive individuals: results from NHANES. Front Immunol 2023, 14, 1087345.
  28. Cheng, T.; Yu, D.; Tang, Q.; et al. Gender differences in the relationship between the systemic immune‑inflammation index and all‑cause and cardiovascular mortality among adults with hypertension: evidence from NHANES 1999‑2018. Front. Endocrinol. 2024, 15, 1436999.
  29. Johnson, A.E.; Bulgarelli, L.; Shen, L.; et al. MIMIC‑IV, a freely accessible electronic health record dataset. Scientific Data Data 2023, 10, 1. DOI: http://doi.org/10.1038/s41597-022-01899-x
  30. Zhao, D.; Liu, Y.; Chen, S.; et al. Predictive value of blood urea nitrogen to albumin ratio in long‑term mortality in intensive care unit patients with acute myocardial infarction: A propensity score matching analysis. Int. J. Gen. Med. 2022, 2247–2259. DOI: http://doi.org/10.2147/ijgm.S349722
  31. Zhao, H.; Wang, M.; Gao, Y.; et al. Vespakinin‑M, a natural peptide from Vespa magnifica, promotes functional recovery in stroke mice. Commun. Biol. 2022, 5, 74. DOI: http://doi.org/10.1038/s42003-022-03024-5
  32. Lai, A.K.W.; Ng, T.C.; Hung, V.K.L.; et al. Exacerbated VEGF up‑regulation accompanies diabetes‑aggravated hemorrhage in mice after experimental cerebral ischemia and delayed reperfusion. Neural Regen. Res. 2022, 17, 1566–1575. DOI: http://doi.org/10.4103/1673-5374.330612
  33. Resl, M.; Clodi, M. Diabetes and cardiovascular complications: Epidemiologie zur Morbidität und Mortalität. Wiener Med Wochenschr 2010, 160, 3–7.
  34. Chen, W.; Huang, W.; Yang, Y.; et al. Methylglyoxal Scavengers Attenuate Angiogenesis Dysfunction Induced by Methylglyoxal and Oxygen‑Glucose Deprivation. Oxid. Med. Cell. Longev. 2022, 2022, 8854457. DOI: http://doi.org/10.1155/2022/8854457
  35. Sibony, R.W.; Segev, O.; Dor, S.; et al. Overview of oxidative stress and inflammation in diabetes. J Diabetes 2024, 16, e70014. DOI: http://doi.org/10.1111/1753-0407.70014
  36. Hwang, Z.A.; Li, C.W.; Lin, C.Y.E.; et al. Intensity of arterial structure acquired by Silent MRA estimates cerebral blood flow. Insights Imaging 2021, 12, 1–9. DOI: http://doi.org/10.1186/s13244-021-01132-0
  37. Kong, L.L.; Wang, Z.Y.; Han, N.; et al. Neutralization of chemokine‑like factor 1, a novel CC chemokine, protects against focal cerebral ischemia by inhibiting neutrophil infiltration via MAPK pathways in rats. J. Neuroinflammation. 2014, 11, 1–10. DOI: http://doi.org/10.1186/1742-2094-11-112
  38. Yen, F.S.; Wei, J.C.C.; Chiu, L.T.; et al. Diabetes, hypertension, and cardiovascular disease development. J. Transl. Med. 2022, 20, 1–12. DOI: http://doi.org/10.1186/s12967-021-03217-2
  39. Zhang, X.; Kang, Z.; Yin, D.; et al. Role of neutrophils in different stages of atherosclerosis. Innate Immun. 2023, 29, 97–109. DOI: http://doi.org/10.1177/17534259231189195
  40. Hartwig, H.; Roig, C.S.; Daemen, M.; et al. Neutrophils in atherosclerosis. Hämostaseologie 2015, 35, 121–127. DOI: http://doi.org/10.5482/hamo-14-09-0040
  41. Luo, J.; Thomassen, J.Q.; Nordestgaard, B.G.; et al. Neutrophil counts and cardiovascular disease. Eur. Heart J. 2023, 44, 4953–4964. DOI: http://doi.org/10.1093/eurheartj/ehad649
  42. Beckman, J.A.; Creager, M.A.; Libby, P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002, 287, 2570–2581. DOI: http://doi.org/10.1001/jama.287.19.2570
  43. Chen, X.; Li, A.; Ma, Q. Neutrophil–lymphocyte ratio and systemic immune‑inflammation index as predictors of cardiovascular risk and mortality in prediabetes and diabetes: a population‑based study. Inflammopharmacology 2024, 32, 3213–3227. DOI: http://doi.org/10.1007/s10787-024-01559-z
  44. Yao, H.W.; Kuan, C.Y. Early neutrophil inϐiltration is critical for inflammation‑sensitized hypoxic‑ischemic brain injury in newborns. J. Cereb. Blood Flow Metab. 2020, 40, 2188–2200. DOI: http://doi.org/10.1177/0271678x19891839
  45. Cui, L.L.; Zhang, Y.; Chen, Z.Y.; et al. Early neutrophil count relates to infarct size and fatal outcome after large hemispheric infarction. CNS Neurosci. Ther. 2020, 26, 829–836. DOI: http://doi.org/10.1111/cns.13381
  46. Cai, W.; Liu, S.; Hu, M.; et al. Functional dynamics of neutrophils after ischemic stroke. Transl. Stroke Res. 2020, 11, 108–121.
  47. Zhang, W.B.; Zeng, Y.Y.; Wang, F.; et al. A high neutrophil‑to‑lymphocyte ratio predicts hemorrhagic transformation of large atherosclerotic infarction in patients with acute ischemic stroke. Aging 2020, 12, 2428.
  48. Mahemuti, N.; Jing, X.; Zhang, N.; et al. Association between systemic immunity‑inflammation index and hyperlipidemia: a population‑based study from the NHANES (2015–2020). Nutrients 2023, 15, 1177.
  49. Menyhart, O.; Fekete, J.T.; Győrffy, B.; et al. Inflammation and colorectal cancer: a meta‑analysis of the prognostic significance of the systemic immune–inflammation index (SII) and the systemic inflammation response index (SIRI). Int. J. Mol. Sci. 2024, 25, 8441. DOI: http://doi.org/10.3390/ijms25158441
  50. Sun, J.; Qi, Y.; Wang, W.; et al. Systemic immune‑inflammation index (SII) as a predictor of short‑term mortality risk in sepsis‑associated acute kidney injury: A retrospective cohort study. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2024, 30, e943414‑1. DOI: http://doi.org/10.12659/msm.943414
  51. Moisa, E.; Corneci, D.; Negoita, S.; et al. Dynamic changes of the neutrophil‑to‑lymphocyte ratio, systemic inflammation index, and derived neutrophil‑to‑lymphocyte ratio independently predict invasive mechanical ventilation need and death in critically ill COVID‑19 patients. Biomedicines 2021, 9, 1656.
  52. Xiao, S.; Wang, X.; Zhang, G.; et al. Association of systemic immune inflammation index with estimated pulse wave velocity, atherogenic index of plasma, triglyceride‑glucose index, and cardiovascular disease: a large cross‑sectional study. Mediators Inflamm. 2023, 2023, 1966680.
  53. Li, G.; Yu, J.; Jiang, S.; et al. Systemic Immune‑Inflammation Index Was Significantly Associated with All‑Cause and Cardiovascular‑Specific Mortalities in Patients Receiving Peritoneal Dialysis. J. Inflamm. Res. 2023, 16, 3871–3878. DOI: http://doi.org/10.2147/jir.S426961
  54. Lai, W.; Xie, Y.; Zhao, X.; et al. Elevated systemic immune inflammation level increases the risk of total and cause‑specific mortality among patients with chronic kidney disease: a large multi‑center longitudinal study. Inflammation Res. 2023, 72, 149–158. DOI: http://doi.org/10.1007/s00011-022-01659-y
  55. Hu, J.; Wang, L.; Fan, K.; et al. The association between systemic inflammatory markers and post‑stroke depression: a prospective stroke cohort. Clin. Interv. Aging 2021, 16, 1231–1239. DOI: http://doi.org/10.2147/cia.S314131
  56. Lee, M.; Lee, E.J.; Kim, R.O.; et al. Systemic immune‑inflammation index as a predictor of early stroke progression/recurrence in acute atherosclerotic ischemic stroke. Clin. Neurol Neurosurg. 2024, 238, 108182. DOI: http://doi.org/10.1016/j.clineuro.2024.108182